Indications
Hemorrhoids (internal and external).
$40.00
Active ingredient: | |
---|---|
Dosage form: | |
Indications for use: |
Hemorrhoids (internal and external).
Rectally. With severe clinical symptoms,1 suppository is administered in the morning and evening. In case of regression of acute symptoms – 1 suppository 1 time a day.
Hypersensitivity to the components of the drug, liver failure, pregnancy (I trimester).
1 suppository contains
Active ingredients:
tribenoside 400.00 mg,
lidocaine base 40.00 mg.
Auxiliary substances:
suppository weight n° 1 (Vitepsol E 85) 305.00 mg, suppository weight n° 2 (Vitepsol W35) 1255.00 mg.
1 suppository contains
Active ingredients:
tribenoside 400.00 mg,
lidocaine base 40.00 mg.
Auxiliary substances:
Suppository mass n° 1 (Vitepsol E 85) 305,00 mg, suppository mass n° 2 (Vitepsol W35) 1255,00 mg
Pharmacotherapy group: a means of treating hemorrhoids. ATX code: From 05 TO 03.
Pharmacological properties
Combined anti-hemorrhoidal remedy. Tribenoside reduces capillary permeability and improves vascular tone; it has an antagonistic effect on some endogenous substances that act as mediators in the development of inflammation and pain. Lidocaine has a local anesthetic effect. The drug causes rapid relief of symptoms caused by hemorrhoids (pain, itching, and skin tension).
Pharmacokinetics.
The systemic bioavailability of tribenoside coming from the suppository reaches 30% of the amount that is absorbed when the drug is taken orally (in the form of capsules). Reaching the maximum plasma concentration of 1 mcg / ml (tribenoside+metabolites) is observed 2 hours after rectal use of 1 suppository (400 mg of tribenoside). Tribenoside is largely metabolized in the liver. 20-27% of the administered dose is excreted in the urine as metabolites.
Hemorrhoids (internal and external).
Use caution during pregnancy, especially in the first trimester.
During breastfeeding, use is possible without stopping breast-feeding, if the expected effect of therapy exceeds the potential risk to the child.
Hypersensitivity to the components of the drug, liver failure, pregnancy (I trimester).
From the immune system:
Very rare (
Skin and subcutaneous tissue disorders:
Rare (>1/10 000, >
These symptoms may extend beyond the site of application.
No cases of interaction were registered.
Rectally. With severe clinical symptoms,1 suppository is administered in the morning and evening. In case of regression of acute symptoms – 1 suppository 1 time a day.
No cases of drug overdose have been reported. In case of accidental ingestion, gastric lavage is recommended, as well as symptomatic maintenance therapy.
Solid rectal suppositories are torpedo-shaped, without cracks, slightly greasy to the touch, yellowish-white in color, with a faint specific smell.
If the existing symptoms of the disease do not decrease during treatment or new unusual sensations appear, you should consult a doctor. When using Procto-glivenol®, it is necessary to monitor the hygiene of the anal area, avoid excessive tension, and take measures to maintain a soft stool consistency.
Influence on the ability to drive vehicles and mechanisms:
In dosages not exceeding the recommended ones, the drug does not affect the ability to perform work related to the need for concentration of attention, rapid mental and motor reactions.
Rectal suppositories
At a temperature not exceeding 30 °C. Keep out of reach of children.
life is 5 years. Do not use after the expiration date indicated on the package.
Lidocaine, Tribenoside
rectal suppositories
For adults
Hemorrhoid
Reviews
There are no reviews yet